AC Immune SA (ACIU) is a publicly traded Healthcare sector company. As of May 21, 2026, ACIU trades at $2.89 with a market cap of $281.91M and a P/E ratio of 0.00. ACIU moved +2.13% today. Year to date, ACIU is -17.90%; over the trailing twelve months it is +65.14%. Its 52-week range spans $1.43 to $4.00. Analyst consensus is strong buy with an average price target of $10.00. Rallies surfaces ACIU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
AC Immune SA (ACIU) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ACIU moved +2.13% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $2.89 |
| Market Cap | $281.91M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.00 |
| 52-Week Low | $1.43 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
3 analysts cover ACIU: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.00.